Gary M. Phillips

Gary M. Phillips, MD, holds prominent leadership roles in the biopharmaceutical industry, currently serving as Chairman of the Supervisory Board at BioConnection and Nanobiotix, Chief Business Officer at ANAVEON AG, and a board member at multiple organizations including Aldeyra Therapeutics and ORYN THERAPEUTICS, LLC. With a distinguished career that includes past positions as President and CEO of OrphoMed, and Executive Vice President at Mallinckrodt Pharmaceuticals, Gary's expertise encompasses strategic management and business development in healthcare. Academic credentials include a Doctor of Medicine from the University of Pennsylvania School of Medicine, an MBA from The Wharton School, and a Bachelor of Arts in Biochemistry from the University of Pennsylvania.